Amdocs Limited (NASDAQ:DOX) Shares Sold by Mather Group LLC.

Mather Group LLC. trimmed its holdings in Amdocs Limited (NASDAQ:DOXFree Report) by 9.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 2,430 shares of the technology company’s stock after selling 264 shares during the quarter. Mather Group LLC.’s holdings in Amdocs were worth $214,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Acadian Asset Management LLC purchased a new stake in shares of Amdocs in the 3rd quarter valued at about $96,934,000. Invesco Ltd. raised its holdings in shares of Amdocs by 31.0% in the third quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company’s stock valued at $222,153,000 after buying an additional 621,962 shares during the last quarter. Qube Research & Technologies Ltd boosted its stake in shares of Amdocs by 333.7% during the third quarter. Qube Research & Technologies Ltd now owns 449,788 shares of the technology company’s stock worth $38,003,000 after buying an additional 346,071 shares during the period. Meitav Investment House Ltd. increased its position in Amdocs by 2,132.9% in the 3rd quarter. Meitav Investment House Ltd. now owns 299,214 shares of the technology company’s stock valued at $25,609,000 after acquiring an additional 285,814 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Amdocs by 39.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 796,767 shares of the technology company’s stock valued at $67,319,000 after purchasing an additional 224,518 shares during the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Price Performance

Amdocs stock opened at $83.90 on Friday. The company has a market cap of $9.86 billion, a P/E ratio of 17.97, a price-to-earnings-growth ratio of 1.35 and a beta of 0.70. Amdocs Limited has a one year low of $78.38 and a one year high of $99.75. The business has a fifty day moving average of $88.95 and a two-hundred day moving average of $87.39. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The firm had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same quarter last year, the business earned $1.33 earnings per share. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, analysts predict that Amdocs Limited will post 5.87 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were paid a $0.479 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 annualized dividend and a yield of 2.28%. The ex-dividend date was Wednesday, March 27th. Amdocs’s dividend payout ratio (DPR) is presently 41.11%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DOX. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Citigroup upped their price objective on shares of Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Finally, Barclays lifted their target price on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Five analysts have rated the stock with a buy rating, According to MarketBeat, Amdocs presently has a consensus rating of “Buy” and a consensus target price of $108.60.

Get Our Latest Analysis on Amdocs

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.